Loading
ReadUpdated Oct 2, 2026
Analysis
Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
Published pieces336 in the archive
Current leadPolicy monitoring
SourcingCitable public records
Written forImport and customs teams
Browse
Topics
Trade policy105 piecesPolicy monitoringTrade remedies15 piecesAD/CVD ordersInjury determination+1Export controls19 piecesLicensing regimeFDPR enforcement+2Tariff authority72 piecesSection 301 trackSection 122 surcharge+2Customs enforcement33 piecesClassification and valuationUFLPA enforcement+2Metals scope review10 piecesSection 232 metalsSection 232 copper+1Origin review30 piecesUSMCA reviewAuto rules of origin+1Trade governance10 piecesAdvisory committeeEXIM reauthorization+1Entry posture review39 piecesRefund postureCAPE processing+3Tariff relief2 piecesExclusion process
Filtered
Origin review stream
2028 Generic Drug Tariff Still Lacks a Product Identity Rule
The announced 2028 generic drug tariff cannot reward a U.S. plant until the government decides how API origin and ANDA sites identify an American product. Entry records add a third test, making the two-year runway a qualification and site-transfer clock.
Canada Section 338 Tariffs Put HTS Scope Ahead of USMCA
Canada's new Section 338 tariffs use three disjoint Chapter 99 headings under one shared U.S. Note 51. USMCA origin can still set the base rate, but it does not exempt a listed product from the added 50%. Import teams should map HTS scope before the August 19 entry date.
